[Influence of tumor necrosis alpha blockade with infliximab on lipid profile in patients with active rheumatoid arthritis].
Pérez-Galán
María José
MJ
Salvatierra-Ossorio
Juan
J
Cáliz-Cáliz
Rafael
R
Guzmán-Ubeda
Manuel Alejandro
MA
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D008076:Cholesterol, HDL / Q000378:metabolism*; D008078:Cholesterol, LDL / Q000378:metabolism*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab